Page 2 - சித்தாந்த் கண்டெகர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சித்தாந்த் கண்டெகர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சித்தாந்த் கண்டெகர் Today - Breaking & Trending Today

Divi's Lab, one of best performing large-cap stocks, sees wave of bullish calls

Divi’s Lab, one of best performing large-cap stocks, sees wave of bullish calls
Premium
(REUTERS)
Ronojoy Mazumdar
, Bloomberg
Overall in absolute terms, analysts’ average 12-month target price for Divi’s stock has risen about ₹134 in the past four weeks
Share Via
Some analysts are turning even more bullish on India’s best-performing large-cap stock in 2020.
In just about two weeks, at least four brokerages have raised their price targets on Divi’s Laboratories Ltd., one of the top producers of active pharmaceutical ingredients, with Jefferies India Pvt.’s estimate which targets a 21% gain over the next 12 months from current levels being the most bullish in data compiled by Bloomberg. ....

Andhra Pradesh , Tushar Manudhane , Bharti Airtel , Siddhant Khandekar , Abhishek Sharma , India Health Care Index , Motilal Oswal Financial Services Ltd , Spicejet Ltd , Divi Lab , Drug Administration , Interglobe Aviation Ltd , Contract Research Manufacturing Services , Divi Laboratories Ltd , Laboratories Ltd , Jefferies India , File Photo , Health Care , Motilal Oswal Financial Services , View Full , Contract Research , Manufacturing Services , Join Mint , Divis Laboratories , Divis Lab , Divis Stock , Divis Stock Price Today ,

India's best-performing stock is seeing a wave of optimistic calls

India’s best-performing stock is seeing a wave of optimistic calls
Indian API exporters have been increasing their share of the U.S. market at the expense of Europe and China-based rivals
(HT PRINT)Premium
Some analysts are turning even more bullish on India’s best-performing large-cap stock in 2020.
Share Via
Some analysts are turning even more bullish on India’s best-performing large-cap stock in 2020.
In just about two weeks, at least four brokerages have raised their price targets on the shares of Divi’s Laboratories Ltd. one of the top producers of active pharmaceutical ingredients with Jefferies India Pvt.’s estimate of an almost 20% gain over the next 12 months being the most bullish in data compiled by Bloomberg. ....

Andhra Pradesh , Tushar Manudhane , Siddhant Khandekar , Abhishek Sharma , Crompton Greaves , India Health Care Index , Divi Laboratories Ltd , Motilal Oswal Financial Services Ltd , Drug Administration , Jefferies India , November Divi , Health Care , Motilal Oswal Financial Services , India Issues Guideline , Join Mint , Divis Laboratories , ஆந்திரா பிரதேஷ் , துஷார் மனுதேன் , சித்தாந்த் கண்டெகர் , அபிஷேக் ஷர்மா , குரோம்ப்டன் கிரேவ்ஸ் , இந்தியா ஆரோக்கியம் பராமரிப்பு குறியீட்டு , டிவி ஆய்வகங்கள் லிமிடெட் , மோட்டிலால் ஒசுவள் நிதி சேவைகள் லிமிடெட் , ஜெஃப்பெரிஸ் இந்தியா , நவம்பர் டிவி ,

Falling reliance on China: Optimism grows for India's best-performing stock

Some analysts are turning even more bullish on India’s best-performing large-cap stock in 2020.
In just about two weeks, at least four brokerages have raised their price targets on the shares of Divi’s Laboratories Ltd. one of the top producers of active pharmaceutical ingredients with Jefferies India Pvt.’s estimate of an almost 20% gain over the next 12 months being the most bullish in data compiled by Bloomberg.
The optimism is stemming from the company’s capacity-expansion plans and potential to win more business as India cuts its reliance on Chinese suppliers.
”Capital discipline has been one of the hallmarks of this company,” said Siddhant Khandekar, an analyst at ICICIdirect.com. “Divi’s is known for optimum utilization of capital. There must be tangible orders on hand and that is why they are spending.” ....

Andhra Pradesh , Tushar Manudhane , Siddhant Khandekar , Abhishek Sharma , India Health Care Index , Divi Laboratories Ltd , Motilal Oswal Financial Services Ltd , Drug Administration , Jefferies India , November Divi , Health Care , Motilal Oswal Financial Services , Market News , Large Cap , Stock Market , ஆந்திரா பிரதேஷ் , துஷார் மனுதேன் , சித்தாந்த் கண்டெகர் , அபிஷேக் ஷர்மா , இந்தியா ஆரோக்கியம் பராமரிப்பு குறியீட்டு , டிவி ஆய்வகங்கள் லிமிடெட் , மோட்டிலால் ஒசுவள் நிதி சேவைகள் லிமிடெட் , ஜெஃப்பெரிஸ் இந்தியா , நவம்பர் டிவி , ஆரோக்கியம் பராமரிப்பு , மோட்டிலால் ஒசுவள் நிதி சேவைகள் ,

Pharma Firm Divi's Laboratories, India's Best-Performing Stock, Sees Wave of Optimistic Calls due to the company's capacity-expansion plans

Buy
The company s second-quarter earnings topped estimates in early November. Divi s has started building a production facility near Kakinada in India s Andhra Pradesh state, it said in an exchange filing the following month.
Overall in absolute terms, analysts average 12-month target price for Divi s stock has risen about Rs 134 in the past four weeks, the biggest increase among 10 companies on the MSCI India Health Care Index. The stock currently has 17 buy ratings, two holds and three sell recommendations, data compiled by Bloomberg show.
The stock could carry its momentum into this year, said Tushar Manudhane, an analyst at Motilal Oswal Financial Services Ltd. in Mumbai. They have a good track record of using new capacity efficiently. ....

Andhra Pradesh , Tushar Manudhane , Siddhant Khandekar , Abhishek Sharma , India Health Care Index , Motilal Oswal Financial Services Ltd , Drug Administration , Pharma Firm , Best Performing Stock , Sees Wave , Optimistic Calls , Jefferies India , Health Care , Motilal Oswal Financial Services , Divi Amp 039s Laboratories , Large Cap Stock , ஆந்திரா பிரதேஷ் , துஷார் மனுதேன் , சித்தாந்த் கண்டெகர் , அபிஷேக் ஷர்மா , இந்தியா ஆரோக்கியம் பராமரிப்பு குறியீட்டு , மோட்டிலால் ஒசுவள் நிதி சேவைகள் லிமிடெட் , பார்மா நிறுவனம் , சிறந்தது நிகழ்த்துகிறது ஸ்டாக் , பார்க்கிறது அலை , நம்பிக்கை அழைப்புகள் ,

Divis Share Price: India's best-performing stock is seeing a wave of optimistic calls | India Business News

Some analysts are turning even more bullish on India’s best-performing large-cap stock in 2020.
In just about two weeks, at least four brokerages have raised their price targets on the shares of Divi’s Laboratories Ltd. one of the top producers of active pharmaceutical ingredients with Jefferies India Pvt.’s estimate of an almost 20% gain over the next 12 months being the most bullish in data compiled by Bloomberg.
The optimism is stemming from the company’s capacity-expansion plans and potential to win more business as India cuts its reliance on Chinese suppliers.
Capital discipline has been one of the hallmarks of this company,” said Siddhant Khandekar, an analyst at ICICIdirect.com. “Divi’s is known for optimum utilization of capital. There must be tangible orders on hand and that is why they are spending.” ....

Andhra Pradesh , Tushar Manudhane , Siddhant Khandekar , Abhishek Sharma , India Health Care Index , Divi Laboratories Ltd , Motilal Oswal Financial Services Ltd , Drug Administration , Jefferies India , Health Care , Motilal Oswal Financial Services , Business News , Divi X27s Lab Target , Divi X27s Lab Stock Price , Divi X27s Lab Rating , Divi X27s Lab Api , Divi X27s Lab , ஆந்திரா பிரதேஷ் , துஷார் மனுதேன் , சித்தாந்த் கண்டெகர் , அபிஷேக் ஷர்மா , இந்தியா ஆரோக்கியம் பராமரிப்பு குறியீட்டு , டிவி ஆய்வகங்கள் லிமிடெட் , மோட்டிலால் ஒசுவள் நிதி சேவைகள் லிமிடெட் , ஜெஃப்பெரிஸ் இந்தியா , ஆரோக்கியம் பராமரிப்பு ,